NCT01241032View on ClinicalTrials.gov

Phase I Study to Investigate the Alcohol Interaction of DA8159

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

February 28, 2007

Conditions
Healthy VolunteersErectile Dysfunction
Interventions
DRUG

Udenafil

200mg Single Oral Dose of

DIETARY_SUPPLEMENT

Alcohol

Alcohol 39g / 240ml

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Dong-A Pharmaceutical Co., Ltd.

INDUSTRY

lead

Asan Medical Center

OTHER